Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Psyence Biomedical Ltd (PBMWW)

20 + Investors. Track Smart Money conviction in PBMWW. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
→ 0
Streak
1Q —
Buyers last Q
40%

Smart Money Signals — PBMWW

Based on 20 hedge funds · latest filing: 2026 Q1 · updated quarterly

➡️

No change last quarter

last 6Q
The number of hedge funds holding this stock didn't change last quarter. Neither a buying nor selling signal on its own — watch the next quarter for direction.
🔻

Below peak — only 69% of 3.0Y high

69% of all-time peak
Only 20 funds hold PBMWW today versus a peak of 29 funds at 2024 Q1 — just 69% of the maximum. Low institutional ownership can mean the stock is out of favor, but it also means there's a large pool of potential buyers if sentiment turns.
📉

Outflows — 20% fewer funds vs a year ago

fund count last 6Q
5 fewer hedge funds hold PBMWW compared to a year ago (-20% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🟠

More sellers than buyers — 40% buying

2 buying3 selling
Last quarter: 3 funds reduced or exited vs 2 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
➡️

Steady new buyers — ~2 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 2 → 3 → 0 → 2. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

60% of holders stayed for 2+ years

■ 60% conviction (2yr+) ■ 30% medium ■ 10% new
12 out of 20 hedge funds have held PBMWW for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
⚠️

Saturation — most institutions already know this story

5 → 2 → 3 → 0 → 2 new funds/Q
New funds entering each quarter: 2 → 3 → 0 → 2. Far fewer institutions are entering now vs. a year ago. When the pool of potential new buyers shrinks this fast, future price support from institutional inflows weakens significantly.
📊

Mixed cohorts — 10% veterans, 25% new entrants

■ 10% veterans ■ 65% 1-2yr ■ 25% new
Of 20 current holders: 2 (10%) held 2+ years, 13 held 1–2 years, 5 (25%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.
📋

Smaller funds dominant — 8% AUM from top-100

8% from top-100 AUM funds
4 of 19 holders rank in the top 100 by AUM, but together hold only 8% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
2.2
out of 10
Low Exit Risk
Exit risk score 2.2/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — PBMWW

In 2026 Q1, 2 hedge funds were net buyers of PBMWW (2 opened a brand-new position), while 3 reduced or exited (1 trimmed, 2 sold completely) — a 40% buyer ratio, indicating roughly balanced activity. Net fund flow last quarter: flat (entries and exits balanced). Total institutional holders: 20.

Hedge Fund Ownership: PBMWW

How many hedge funds hold PBMWW — quarterly history vs. share price
Quarterly hedge fund ownership of PBMWW vs. share price

Market Analysis: PBMWW

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: PBMWW

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Psyence Biomedical Ltd (PBMWW) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much PBMWW has moved relative to its sector benchmark (SPY) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 29d ago
PBMWW
+74.5%
SPY
-1.4%

PBMWW outperformed SPY by +75.9% since June 30, 2026.

Interpretation: The stock has significantly outperformed its sector benchmark — the original entry opportunity has largely been captured by earlier investors. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

2 top-rated funds 0 high-conviction
Consensus
2.1
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: PBMWW
2026 Q2 Stats Unlock in 21 days 20 + Investors

Track Smart Money conviction in PBMWW. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 20 20 -
13F Shares 5M 6M -3.18%
Total Value $97K $103K -6.29%
New Positions 2 0 +2
Increased Positions 0 1 -1
Closed Positions 2 2 -
Reduced Positions 1 2 -1
Total Calls 1 1 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: PBMWW

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

20 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in PBMWW. Verified SEC 13F-HR filings.

QUARTER:
Top 18 PBMWW holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Harraden Circle Investments, LLC 0.00% 1,150,000 $21K
2 MMCAP International Inc. SPC 0.00% 600,000 $11K
3 Polar Asset Management Partners Inc. 0.00% 733,000 $13K
4 Saba Capital Management, L.P. 0.00% 297,847 $5K
5 Aristeia Capital, L.L.C. 0.00% 215,319 $4K
6 TENOR CAPITAL MANAGEMENT Co., L.P. 0.00% 150,000 $3K
7 Calamos Advisors LLC 0.00% 500,000 $9K
8 Wolverine Asset Management LLC 0.00% 147,101 $3K
9 Clear Street Group Inc. 0.00% 257,209 $5K
10 Toronto Dominion Bank 0.00% 503,312 $9K
11 Parallel Advisors, LLC 0.00% 27,500 —
12 LMR Partners LLP 0.00% 200,000 $4K
13 Ancora Advisors LLC 0.00% 5,000 —
14 D. E. Shaw & Co., Inc. 0.00% 175,352 $3K
15 Millennium Management LLC 0.00% 108,000 $2K
16 Goldman Sachs Group Inc 0.00% 200,117 $4K
17 LPL Financial LLC 0.00% 49,095 —
18 UBS Group AG 0.00% 247 —
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Psyence Biomedical Ltd (PBMWW)

What does the Smart Money Trend signal show for PBMWW?

No change last quarter: The number of hedge funds holding this stock didn't change last quarter. Neither a buying nor selling signal on its own — watch the next quarter for direction.

What is the institutional breadth score for PBMWW?

More sellers than buyers — 40% buying: Last quarter: 3 funds reduced or exited vs 2 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for PBMWW holders?

Smaller funds dominant — 8% AUM from top-100: 4 of 19 holders rank in the top 100 by AUM, but together hold only 8% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held PBMWW?

60% of holders stayed for 2+ years: 12 out of 20 hedge funds have held PBMWW for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Psyence Biomedical Ltd (PBMWW) following the 2026 Q2 hedge fund 13F filings?

Since the quarter end (June 30, 2026), PBMWW has gained +74.5% vs -1.4% for SPY. The stock has significantly outperformed its sector benchmark — the original entry opportunity has largely been captured by earlier investors.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →